Three-dimensional cultures (or “organoids”) derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These “organoid” cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
“This is the first time that a collection of cancer organoids, or a living biobank, has been derived from patient tumors,” says senior study author Mathew Garnett, a geneticist at the Wellcome Trust Sanger Institute. “We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments.”
To study the causes of cancer and develop new cancer treatments, many laboratories use experimental model systems such as cells grown from patient tumors. However, currently available cell lines have been derived under suboptimal conditions and therefore fail to reflect important features of tumor cells. As a result, it has been challenging to predict the drug sensitivity of individual patients based on their unique spectrum of genetic mutations.
In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish. In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present, and their self-renewal properties. Given the advantages of organoids, Garnett and Hans Clevers of the Hubrecht Institute set out to test whether these cultures could potentially bridge the gap between cancer genetics and patient outcomes.
In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures. The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations. These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer.
To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs. Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs. In validation of the approach, the researchers identified previously reported associations between specific mutations and resistance to particular drugs. The organoids also revealed a novel gene-drug association, indicating that the subset of cancer patients with RNF43 mutations would strongly benefit from a drug that inhibits a protein called porcupine. “At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment,” Garnett says.
The Latest on: Organoids
via Google News
The Latest on: Organoids
- Intestinal regeneration: Lessons from organoid researchon October 7, 2020 at 5:01 pm
The last decade has seen a boom in the field of organoids, miniature organs grown from stem cells in vitro. These systems recapitulate the cell type composition and numerous functions of parent ...
- ISSCR launches Digital Meeting Series on Organoidson October 6, 2020 at 5:00 pm
Applying Organoids: The 3D Frontier, co-sponsored by STEMCELL Technologies, will be moderated by Melissa Little, PhD, Murdoch Children's Research Institute, Australia and Toshiro Sato, PhD of Keio ...
- Demand for Organoids for Biomedical and Cancer Research to Expand the Organoids Market Significantly by 2027on September 30, 2020 at 1:08 pm
Sep 29, 2020 (AB Digital via COMTEX) -- Research Nester released a report titled “Organoids Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the ...
- New discovery helps researchers rethink organoid cultureson September 30, 2020 at 8:21 am
Organoids are stem cell-based tissue surrogates that can mimic the structure and function of organs, and they have become a key component of numerous types of medical research in recent years. But ...
- Organoids Market: Growing Concerns about Systematic Treatment Solutions for Personalised Medicine to Drive the Market Growthon September 29, 2020 at 12:45 am
The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation. Recent advancements in Big Data, and technologies ...
- How coronavirus kickstarts deadly lung inflammationon September 28, 2020 at 10:28 am
Researchers studying “lung organoids” infected with SARS-CoV-2 are discovering new insights into how the coronavirus kicks off a cascade of tissue inflammation in the lungs. That reaction can ...
- What are Lung Organoids?on September 25, 2020 at 8:17 pm
Studying lungs can be difficult, due to their complicated structure, but lung organoids can aid in this. Lung organoids are collections of lung-derived epithelial cells grown in a 3D culture ...
- Next-gen organoids grow and function like real tissueson September 16, 2020 at 4:27 pm
Organoids are fast-becoming one of the most cutting-edge tools of modern life sciences. The idea is to use stem cells to build miniature tissues and organs that accurately resemble and behave like ...
- Generation of three-dimensional heart organoidson September 15, 2020 at 5:00 pm
Researchers engineered three-dimensional functional heart organoids resembling the developing heart. By exposing mouse embryonic stem cells to two key proteins during heart development ...
- Organoids emerge as powerful tools for disease modeling and drug discoveryon September 15, 2020 at 5:47 am
But these tissues, called organoids, are enabling scientists to study biological processes in health and disease—and find potential new treatment strategies—in ways they couldn't before.
via Bing News